COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF FACTOR XII
摘要
RNA interference (RNAi) triggers for inhibiting the expression of Factor XII (F12) gene through the mechanism of RNA interference are described. Pharmaceutical compositions comprising one or more F12 RNAi triggers together with one or more excipients capable of delivering the RNAi trigger(s) to a liver cell in vivo are also described. Delivery of the F12 RNAi trigger(s) to liver cells in vivo provides for inhibition of F12 gene expression and treatment of angioedema, including hereditary angioedema (HAE) and venous thromboembolism (VTE), and diseases associated with angioedema.
申请公布号
WO2016149331(A2)
申请公布日期
2016.09.22
申请号
WO2016US22591
申请日期
2016.03.16
申请人
ARROWHEAD RESEARCH CORPORATION
发明人
KANNER, Steven, B.;LEWIS, David, L.;WAKEFIELD, Darren, H.;ALMEIDA, Lauren, J.